Evidence map›Paper›PMID 39375107›Full record

ReviewZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2024

[Application of zinc agents in Wilson's disease].

C Liang, W Hou, Z P Duan, S J Zheng

Abstract readReviewEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Review in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

C LiangThe First Department of Liver Center, Beijing YouAn Hospital, Capital Medical University,Beijing 100069, China Beijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Ｒesearch, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China.
W HouThe First Department of Liver Center, Beijing YouAn Hospital, Capital Medical University,Beijing 100069, China.
Z P DuanThe Fourth Department of Liver Center, Beijing YouAn Hospital, Capital Medical University, Beijing 100069,China Beijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Ｒesearch, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China.
S J ZhengThe First Department of Liver Center, Beijing YouAn Hospital, Capital Medical University,Beijing 100069, China.

Funding

Beijing Hospital Management Center Key Medical Professional Development Plan ZYLX202125Beijing Science and Technology New Star Program Cross-cooperation Project 20230484455Capital Health Development Scientific Research Project 2022-1-2182High-level Public Health Technical Talents of Beijing Municipal Health Commission Academic Leader -02-14Natural Science Foundation of Beijing Municipality 7202068, 7222093
6 · The paper itself

Abstract

Wilson's disease (WD) is a kind of inherited metabolic liver disease in which most patients need lifelong medication to maintain copper homeostasis in the body. Zinc is one of the most commonly used drugs for WD treatment. However, there are currently few high-quality, large-sample, and prospective clinical trials on zinc agent-treated WD. The selection and application of zinc agents are mainly based on patients' clinical phenotype, tolerance to zinc agents, and physicians' experience in treating WD. This article summarizes the application of zinc agents in WD.

Indexed as

Hepatolenticular DegenerationZincCopperHumansCopperZinc

Identifiers

PMID39375107
PMCPMC12898768

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.